U.S. FTC approves Hikma deal for Custopharm with conditions

United States News News

U.S. FTC approves Hikma deal for Custopharm with conditions
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 97%

Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. Federal Trade Commission said on Tuesday.

Pharmacists at Hikma Pharmaceuticals package generic versions of ciprofloxacin hydrochloride 750 mg for export to the U.S. and Western markets in Amman, Jordan February 8, 2011. REUTERS/Ali Jarekjihas won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. Federal Trade Commission said on Tuesday.

Hikma, which makes anesthetics, pain medications, sedatives, neuromuscular agents and other drugs, announced the deal in September as a way for it to strengthen its injectable treatments unit in the United States. It was valued at $425 million at that time.Under a deal struck with the FTC, Custopharm's parent company will retain assets related to the corticosteroid drug triamcinolone acetonide, or TCA, by shifting it to another subsidiary.

"Hikma’s acquisition of Custopharm's TCA business could have caused significant harm for patients who use TCA to treat severe skin conditions, allergies, and inflammation," Holly Vedova, director of the FTC’s Bureau of Competition, said in a statement.Reporting by Diane Bartz; Editing by Aurora EllisSign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

SEC Risks Violating Admin Procedure Act by Rejecting Spot Bitcoin ETFs, Says Grayscale – Regulation Bitcoin NewsSEC Risks Violating Admin Procedure Act by Rejecting Spot Bitcoin ETFs, Says Grayscale – Regulation Bitcoin NewsGrayscale Investments' CEO explains that the U.S. Securities and Exchange Commission (SEC) could potentially violate the Administrative Procedure Act by not approving a spot bitcoin exchange-traded fund (ETF).
Read more »

Commanders deny allegations of financial improprieties in lengthy letter to FTCCommanders deny allegations of financial improprieties in lengthy letter to FTCIn an 18-page letter, the NFL team said allegations by a former employee of long-running financial improprieties are “baseless” and that an investigation is unwarranted.
Read more »

Another man dies after car crashes into canal in Summit CountyAnother man dies after car crashes into canal in Summit CountyPolice say the third man is in critical condition.
Read more »

PM Update: Rain continues this evening ahead of a wind-chilled TuesdayPM Update: Rain continues this evening ahead of a wind-chilled TuesdayThe storm passes tonight, but unsettled conditions persist tomorrow.
Read more »

Florida Chihuahua believed to be world’s oldest dogFlorida Chihuahua believed to be world’s oldest dogThe dog continues to be active despite a mild heart condition.
Read more »

Shanghai Reports First Covid-19 Deaths Since Start of LockdownShanghai Reports First Covid-19 Deaths Since Start of LockdownShanghai’s health authorities said three Covid-19 patients have died, the first Covid-related deaths to be reported in the city since a widespread outbreak last month prompted a citywide lockdown
Read more »



Render Time: 2025-03-12 17:53:08